Antipodes Partners’s Zymeworks ZYME Stock Holding History

Antipodes Partners’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$34.6K	Buy	+1,306	New	+$33.8K	﹤0.01%	128

Other funds holding ZYME

BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Hillsdale Investment Management Toronto, Ontario, Canada $4.42B AUM 54.57% 1-Year Est. Return

Antipodes Partners's ZYME Position: Q3 2026 in Review

Antipodes Partners opened a new position in Zymeworks (ZYME) in Q3 2026: 1,306 shares worth $34.6K. The stake represents ﹤0.01% of the portfolio and ranks #128 among its holdings.

133 funds tracked by Wall St. Rank hold ZYME as of Q3 2026.

Antipodes Partners held 1,306 shares of Zymeworks worth $34.6K as of Q3 2026.
Zymeworks was a new Antipodes Partners position in Q3 2026.
Zymeworks made up ﹤0.01% of Antipodes Partners's portfolio in Q3 2026, its #128 holding.
133 funds tracked by Wall St. Rank held Zymeworks as of Q3 2026.

Based on Antipodes Partners's 13F filing for Q3 2026, filed 5 Nov 2026.